Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295211
Status:
COMPLETED
Last Update Posted:
2024-03-06
First Post:
2024-02-23
Brief Title:
Brentuximab Vedotin Combined With Bendamustine Supercharge a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma Long-term Results of a Retrospective Monocenter Study
Sponsor:
Federico II University
Organization:
Federico II University
Organization Data
Organization:
Federico II University
Class:
OTHER
Study ID:
FEDII_HL_PRR-Bv-Bs
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Federico II University
Lead Sponsor Class:
OTHER
Responsible Party:
Marco Picardi
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Federico II University
Old Name:
None
Old Organization:
None